Reddit Posts
FDA granted fertility treatment to FEMY
Stocks to have an eye on for Monday
The most active penny stocks worth your time: FEMY, TLRY, OLB, NKLA
MicroCap Movers this Coming Week : $UNQL, $VISM, $MIMO, $OPGN, $FEMY
MicroCap Movers Last Week : $UNQL, $VISM, $MIMO, $OPGN, $FEMY
Very new to investing/trading. Please give opinion
FEMY jumps on FDA approval: Is Femasys a hidden gem for investors?
How is this stock not skyrocketing?! (Femasys- FEMY)
Roe v Wade Overturned - Buy Birth Control / Contraception stocks?
Roe v Wade Overturned - Buy Birth Control / Contraception stocks?
Roe v Wade Overturned - Buy Birth Control / Contraception stocks?
BJDX - ADTX - FEMY - All set to Fly
Mentions
All my stocks/crypto have been poop. Overall I’ve won a little and lost multiples of that but not playing with a ton of money so basically $40 in the hole. Still have some stuff like OLOX and TPET, DVLT, FEMY - some others I can’t remember. Idk, it’s fun to play. More fun when green numbers go brrr. Who would’ve thought buying something called FARTCOIN would be (at least short term) not a profitable investment?
NRXP CGTX!!! Lets go FEMY BOIS
Picking up more FEMY on today's dip. Earnings tomorrow with recent setup for institutional buy in at 0.58 (currently at 0.51)
Every time someone says FEMY i think of femboys and that makes me want to invest no questions asked
Anyone in FEMY? Been stuck in support at .50s for a while, but has had new product approvals and sales over last quarter or two. Earnings tomorrow. Expect the company to pump it to meet NASDAQ compliance by July
I added more IMRX yesterday and now have 323 shares with avg 4.35$. I also bought FEMY stock a small amount (300 shares) at 0.6 even though I'm overextended in med stocks but extra 180$ is not much for such amount of shares and potential though. It is dangerous pick because it has reverse split looming in July but the upcoming ER could push it past 1$ and if you ignore the possible reverse split (which is obviously hard to ignore lol), it has already revenue generating products and more coming in the pipeline. Also I previously had 200 shares of High Tide and added extra 100 shares after great quarter earnings even though the share price dropped in market openings like a rock even after move up, but not so much as Palladyne after their latest contract announcement which is really "WTF is going on" which moved to 7.5 pre-market oppen and dropped to 6.3 like in a hour after market openings and started in 6.9 instantly when market opened. High Tide is a Canadian cannabis stock which is not the most attractive sector but this company is the exception because it has great fundamentals/financials and outlook (it is expanding aswell), undervalued (IMO) and could be a significant player when cannabis is more widely legalized in USA (it is pretty much leading the pack in retail cannabis in Canada). It kind of has the same vibe as LifeMD which has bigger competitor Hims&Hers which everybody focuses on, High Tide is less talked about and usually Tilray is the company that is focused on but High Tide has better financials even though the revenue is smaller, potentially great outlook in the future, low debt and good leadership aswell. I think this company may be worthy to DD for you, it is less speculative and with good fundamentals even though the cannabis sector is highly competitive but they focus on retail aspect of cannabis sector and have strong footing in there.
Yes! I'm invested in a few other cancer stocks that could go high based on current share price - MAIA, AUTL, CHRS. But IOVA is a strong contender. Outside of that I'd bet DVLT, NRXP and FEMY (heavy on this choice because they have so much going for them).
Anyone looking at $FEMY?
i’ve been keeping an eye on FEMY too, seems like it’s hit that sweet spot for a potential breakout. the consolidation around $0.50–$0.60 could really be the calm before the storm. if they can hit that $1 mark, it might attract more attention from those momentum traders you mentioned. plus, with their pivotal trial moving forward, it feels like there’s a lot of upside if things play out well. just hoping the earnings give us that extra push! what do you think the timeline looks like for those updates?
Yeah FEMY has definitely had a road getting here. The interesting part now is how much the product side has expanded since then. Multiple devices already in OB-GYN clinics and additional launches expected this year. For a ~$35M company it’s at least an interesting setup to watch. If anything, the company looks more operationally mature now than when a lot of people first discovered it.
Dang I remember first finding out about $FEMY ~2 years ago & watching it fight for compliance…
I agree mate! FEMY is definitely one of the longer growth stocks. A tale tell sign is that they’re already FDA approved on products in their portfolio, as we await trial on FemBloc - the flagship product of the company! Analysts are predicting the brand should see a revaluation soon as well accurately to around $5 -$6/ a share at current levels. Could very well easily see that on any awaited catalyst update or volume pop soon!
Fair enough, a lot of us have bags somewhere in this market. The difference here is FEMY actually has multiple commercial products already on the market and a pipeline still moving forward. FemBloc is in its pivotal trial, the company has been expanding its fertility product line, and the latest investor update shows FemSperm expected to launch in the U.S. this year. For a company sitting around a ~$20–30M valuation, that’s the kind of setup some people look for before things rerate.
totally agree, FEMY is definitely a sleeper right now. the fact that they're in a pivotal trial for FemBloc could change the game for them, especially with Essure gone. the market for women’s reproductive health is kinda wide open, so if they can nail this trial, the upside could be huge. plus, the recent financing gives them a bit more breathing room. earnings coming up should give us a better look at enrollment and cash runway too, which is super important. i’m keeping a close eye on this one for sure! anyone else think they’ll hit the target in the trial?
I’ve tried telling you guys it’s currently way underpriced. FEMY spent the last 4-6 months quietly building a base around $0.40-$0.60. The new investor deck quietly dropped a market changing catalyst in its updated slides last week for FemSperm. The company has yet to announce. Therefore not currently priced in. FEMY is definitely a 2026 one to watch in women’s healthcare!
totally agree! the gap in the market after Essure is huge, and FEMY might really capitalize on that if the FemBloc study goes well. with it hanging around $0.50, it feels like a solid risk/reward play, especially with the short interest. could definitely see a squeeze if the results are positive. i’m keeping an eye on the enrollment news, that could spark some interest. here’s hoping it breaks out!
FEMY currently is under a 180-day Nasdaq requirement extension valid until July, 2026.
I got an insane cash burn, too as an American citizen 😂👍 institutional backing, grant funding, and sales launched should help offset. Some of your favorites are still in debt ‘til this day while generating meme stock status 😂 FEMY has products, and is actually selling said products.
honestly, $FEMY has been the retail battleground of the month, but the real story is always in the 13F filings, not the hype threads. real talk, when you see a massive spike in institutional ownership alongside a 30% price drop, it’s usually one of two things: either a major fund is liquidating a position for non-fundamental reasons (like a redemptions call), or they’re "loading the boat" while retail panic-sells. ngl, most people forget that institutions have a 3–5 year horizon while retail is looking at the 3-minute candle lol. the "gamble" here isn't the science the data on their pipeline is public it's the cash runway. if they have to do a dilutive offering before the next major catalyst, the institutions will be the ones getting the sweetheart warrants while retail gets washed out. i've learned the hard way that following the "smart money" only works if you have the same bankroll and patience they do. be careful catching falling knives unless you've mapped out the dilution risk.
I bought in on that IVDA dip, hoping to see them BLNK, and FEMY break a dollar in the coming month. ONL, GGB, NSPCY, PLBY, MBOT, DFLI I'm holding till penny stock graduation. I think its fully possible for these peeps.
I'm routing for DFLI, BLNK, PLBY, and FEMY. I wanna believe analyst with their price goals connected to each share, but with DFLI I feel like I lack the understanding on why its price target is 17$ from its current 2$. Is it really that shorted?
I’m really unhappy in my relationships with CALC & FEMY, it gets worse every day. I took up w JTAI cuz I thought I deserved something fun, now it says it’s pregnant. I should’ve broken up w all of them when I had the chance. I was with CALC for MONTHS, and it wasn’t all bad but we grew apart & I finally bailed a few weeks ago but I just had to take that one last stroll down memory lane and wet my beak one last time for old time’s sake, well wet it I indeed did, knocked it up this time & wants to get married. You’d think I’d stopped thinking with my Dick by now, amazing…
FEMY going to be my play for tomorrow
FEMY Trading around $0.65 with $38M market cap, but has a very good non-surgical female sterilization product already approved in EU, UK, NZ and Israel and in final phase of FDA trials. If it captured even a third of the market share it's billions in revenue. Certainly not a sure thing but most 12 month price targets have it 10x'ing. Not a sure thing, but as far as penny stock goes you could do a lot worse.
My usual DFLI, GGB, ONL, PLBY, MBOT, BLNK, FEMY, ADIL, IGC
FEMY starting to run, Up over 17% today on strong volume.
No, thank you. Not FEMY again, please
I love what FEMY is doing but this comment is also great information for anyone buying. Stay informed
They aren’t nasdaq compliant. If a reverse split or delisting is possible, it pressures the stock downward. Most people in it now probably are: 1) already deeply in the red from previous pumps 2) they don’t think a RSS would crash the share price enough to touch their low cost basis (which would be a feat) 3) newer investors who don’t do enough DD on why a stock is so cheap or stagnant Any time a stock is under a dollar, you have to see if it’s Nasdaq or listed under something else. You then need to go digging to see if they are likely to get an extension or not. 1) No insider buying https://www.nasdaq.com/market-activity/stocks/femy/insider-activity 2) lost some institutional investors https://fintel.io/so/us/femy Those are two important groups that aren’t completely sold on FEMY as of right now. Proceed with caution.
Most of them, especially when I was new to trading. Too many speculative biopharma, and I wasn't really looking at things like p/e ratio - just assumed they'd moon. They need capital to do what they do, and they have products with good results that I believe in, but I should have stayed away. BMEA, TOVX, RVPH, INTS, SKYE, HUMA, FEMY, RVPH.
Physical silver and gold. Femasys $FEMY like 5K shares now and liquidate in 5-7 years. Skywater Technology $SKYT like about 2K shares now and liquidate in same time frame, or hold for 20 years and see if they’ve grown enough to have dividends. Energy ETFs.
Put an order in for some FEMY over 2hrs ago and it still hasn’t filled!
IGC, ADIL, DFLI, FEMY, MBOT, PLBY, GGB, BLNK <3 As for crypto FLOKI, and XRP are heavy on my radar
IGC, ADIL for possible commiceralization of their products this year. DFLI, and BLNK with the rise of EV; and a Impending EV mandate. MBOT, FEMY since they start commercialization; bd started pursuing profits. ONL as it should be mostly underway with its assest reassessment which should generate more income abroad. GGB for a long term hold towards rebuilding efforts with Venezuela, and possibly Ukraine if the north american or South america segments decide to export to them (but still probably unlikely atleast from the north american segment with tarrifs). PLBY for retail hype, aswell as possible expanding into profitability going into 2026.
Find a NASDAQ penny stock that has been punished, but on the way back up, has a White Knight now to help finance it with skin in the game and its products will completely disrupt the global market as commercialization kicks in… $FEMY
Is there any bad news recently or dilution risk in the short term for FEMY? 0.60 seems like a great price
FEMY is a great hold the next year or two. CTM has great potential & its just a waiting game at this point.
Thanks FEMY. I guess my son will be getting a head pat and a lesson for Christmas
Anyone holding FEMY through its current dip? Or expecting a longer downturn and getting out until there's a rally (probably later in 2026)?
FEMY being interesting today. Dumping ahead of the possible delisting risk/RS risk @ Jan 12th?
FEMY is cooked, new 8k filed
Those FEMY people about to be real disappointed
Came here to say GANX and FEMY are the two I am most strongly behind.
FEMY. As usual with most penny stocks high risk. Very possible it will do a reverse split to stay in compliance, and those usually result in atleast a short time drop in share price. They should have money until 2027 and they are starting to bring in money from Europe to cover some(but not all) expenses. So dilution still possible. They have a unique patent for FemBloc, so could be bought out. Even if they don't, they have potential to be proftiable in 5-10 year. I'm in with 3000 pcs.
# FEMY, great news jusy out
[https://www.tipranks.com/news/the-fly/femasys-secures-u-s-fda-clearance-for-femvue-controlled-device-thefly?utm\_source=robinhood.com&utm\_medium=referral](https://www.tipranks.com/news/the-fly/femasys-secures-u-s-fda-clearance-for-femvue-controlled-device-thefly?utm_source=robinhood.com&utm_medium=referral) FEMY news drop today
FEMY https://www.stocktitan.net/news/FEMY/
Al those positive news stock drops GANX, FEMY,...
What do we think of FEMY as a mid/long term buy at these $0.88 levels?
Lowkey looking to renter playboy Holding DFLI, FEMY, MBOT, IGC, ADIL, ONL, and IVDA for 2026s bull run
No worries- with how often it happens on the various penny stock communities I don't blame you, I try not to P&D anything. I am interested in squeeze plays if I like the setup/potential but this wasn't that. I swing trade BTC adjacent stocks and jump in on catalysts momentum trades. Normally if I'm in a biotech it's because I like the trend line for it. CABA, RVPH, and FEMY are my favorites rn pennywise and I have PSTV and DRTS but with exception of FEMY I keep those positions to 1-2%. Have some other higher biotechs like CRMD and ABT (I like ABT for its relatively steady growth and think the exact acquisition is a good move as exact also had acquired genomic health in 2019. oncotype dx and cologuard are regularly used at Cleveland clinic and I could see ABTs global presence speeding growth/usage of these once they get regulatory approvals through)
I personally like DFLI, FEMY, IGC, ADIL, ONL, MBOT, and IVDA. The most promising is probably the first 5 tho. I would do dd, but if you have any questions on then from ne; I'll be happy to do my best to answer them.
KITT and FEMY pretty much same chart lol
Doesn’t look legit… https://biopulse-prod.web.app/analysis?ticker=FEMY
DFLI, FEMY, IGC, ADIL, ONL, IVDA, MBOT, CHR (My Pennystock holds, feel free to ask me why) <3
I’ve made good money on FEMY with dips like that. If it gets below .82 I’ll usually throw a good chunk in there and let it stay till it gets above .95. It consistently bounces between low .80s and $1 and has been my go to “safe” choice for weeks lol
Hrmm, last week gave me a false sense of hope for the market. Guess I am not dipping my toes in right now. I kinda like FEMY, but I want to see if it hits the .70s again.
FEMY - FemBloc first and only female permanent contraception without surgical intervention. EMA & MEDSAFE approved. low chance of FDA failure with EMA and MEDSAFE approval \-monopoly \-1-3B market opportunity \-Cheaper than surgical so insurance companies should want it vs tubal ligation \-Less invasive than surgery so Health care should adopt and make this a standard wherever it would not be contraindicated
as well as DVLT for me. I agree with FEMY & LAES
same, both FEMY and LAES right now. The quantum development side has huge forward valuations but the market seems to be ignoring the quantum defence side. FEMY's permanent contraception (FemBloc) is a major healthcare game changer for the future and EMA approval should see it steadily improve 2026
FEMY is my longterm value play, DFLI i'd recommend after their RS which is looking likely to happen. if you're bullish on BTC ASST holds potential but is being heavily manipulated right now
Yes it is a long term investment like FEMY. I have 17k shares of IXHL. Just chilling.
I think it's a long hold, with ups and downs due to those that want an in and out for quick cash, which is the majority o those in this sub. For the time being, it will have to be supported about by how the non-U.S international market deals with results, as those markets tend to be more open to Pharma in that space. The same for FEMY, which probably has a better chance of being acquired, as it is already well thought of outside of the U.S. Both are long holds.
Buying more FEMY, at this point it's my most consistent penny stock... maybe even stock in general.
ABVE might be good in PM or AH, very big institutional efforts to drive price down during regular hours after merger announced on Friday morning. Also looking at PRPH announcement. Keeping my eyes on SATL potential NUAI/DGXX/LAES/POET dips, FEMY (price target currently between $6-12).
Your right no penny stock comes without a risk, however if your concerned with my picks I cant give you a list. MBOT (accumulating for possible profitability next year goal being 4$+) PLBY, My retail pick that broke profitability (found at .89 selling 3$×+) BTLCY, for a reliable and stable REIT with plenty of cash on hand; and prime tenants (found at 4.55 selling 5.10+) DFLI (found at .25, selling 2$+ innovated EV batteries for larger vehicles; and was recognized by both the trucking and battwry community for its innovations with their products) FEMY (found at .75, selling 1.10$+ Innvated Feminine OBGYN care currently going without much contesting in their market since IVF fell) ONL (found 2.10, selling 2.40 REIT thats pays divedends that has a ceo thats a natural to flipping REIT companies; and was confident out valuing a buy out offer they recently turned down) IVDA a data center in arizona thats the easiest of the states data centers to be put on the market (found at .65 selling 1.10$+) Less then 10$, but not penny stocks Nokia (Divdend paying services company. riding out till end of its billion dollar nivida contract in 2026. Found 5.50) Adt (dividend paying serives company. riding out till end of google contract in 2026. Found at 8.15) Overall a services company being out of debt with high institutional/ceo ownership, doesn't mean they have a for sure way to secure profits.
Done with pump and dumps (for now lol), just holding FEMY and MBOT and chill instead of chasing thrill.
DFLI, FEMY with their market specific tech innovations PLBY with rebranding, and royalties deals. BTLCY, ONL undervalued dividend payers
FEMY fight to break a dollar today
I'm a doctor and, I was interested in FEMY so I had a read through the FEMY clinical trials and something they aren't really talking about is that only around 50% of their implantation procedures seem to have resulted in successful bilateral occlusion. They also had issues with their confirmatory test (are the tubes blocked?) in their early trials which resulted in 6 unplanned pregnancies. If you are comparing it to Essure, Essure had an implantation rate well over 90%, and that's generally required for FDA approval. If the proportion of successful implantations doesn't improve (and it has a LONG way to go from 50% in the stage 3 trial stage) then there's no way it'll be approved.
FEMY Chart https://preview.redd.it/p0hb85vc6p3g1.png?width=990&format=png&auto=webp&s=8abbe584069237bf4624b733916367227561ce90
I don’t think there is “convincing info”. They’ve consolidated debt and are working towards profitability, so it seems unlikely to me. But you never know for sure. It’s possible. That’s why penny stocks are considered speculative investments. Personally, I think they’re in a good place and likely to gain value. My penny stock investments are limited to DFLI and FEMY at the moment.
FEMY has been consistently proving itself on the daily.
Holing FEMY, buy-order for CMND (I think the bottom is in), watching AUTL
Thank you for sharing this document! By the way, it's strange that I did not see FEMY on the list. What do you think of the stock and it's potential? They are in stage 3 currently.
Personally very bullish on FEMY, there's still warrants to work through. price has been slightly volatile but with high CTB the shorts aren't looking to dig themselves deeper though they will occassionaly make plays with their available dry powder to try and cause profit taking/sell offs. I see huge upside to the stock and have been in since .67
FEMY back in the game! PharmaCyte Biotech, Inc. (PMCB) ("PharmaCyte" or the "Company"), today announced the successful monetization of its stake in Femasys Inc.(FEMY)
FEMY doing her thing, good company, so safe to hold